Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ibandronate show antifracture efficacy at vertebral sites. Bisphosphonates are generally well tolerated and safe. Nevertheless, adverse events have been noted, and it is important to consider the strength of the evidence for causal relationships. Effects on the gastrointestinal tract and kidney function are well recognized, as are transient acute-phase reactions. Atrial fibrillation was first identified as a potential adverse event in a zoledronate trial, but subsequent trials and analyses failed to substantiate an association with bisphosphonates. Case reports have suggested a relationship between oral bisphosphonates and esophageal cancer, but this has not been demonstrated in epidemiologic studies. A possible association between bisphosphonate use and osteonecrosis of the jaw (ONJ) has also been suggested. However, the risk of ONJ in patients with osteoporosis appears to be very low, with no evidence from prospective RCTs of a causal association. There are reports of occasional occurrence of subtrochanteric or diaphyseal fractures in osteoporotic patients, but an association with bisphosphonate therapy is not substantiated by epidemiologic studies or prospective RCTs.
bisphosphonates, osteoporosis, safety
325-343
Pazianas, Michael
dcba1270-21c4-4b16-b0ca-4ec9ad12eecc
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Ebetino, F. Hal
04c55825-ad41-404d-b5a0-1dc5c5222d9e
Russell, R. Graham G.
055e01f6-6175-4437-aaa0-a78659799dca
July 2010
Pazianas, Michael
dcba1270-21c4-4b16-b0ca-4ec9ad12eecc
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Ebetino, F. Hal
04c55825-ad41-404d-b5a0-1dc5c5222d9e
Russell, R. Graham G.
055e01f6-6175-4437-aaa0-a78659799dca
Pazianas, Michael, Cooper, Cyrus, Ebetino, F. Hal and Russell, R. Graham G.
(2010)
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
Therapeutics and Clinical Risk Management, 21 (6), .
(doi:10.2147/TCRM.S8054).
Abstract
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ibandronate show antifracture efficacy at vertebral sites. Bisphosphonates are generally well tolerated and safe. Nevertheless, adverse events have been noted, and it is important to consider the strength of the evidence for causal relationships. Effects on the gastrointestinal tract and kidney function are well recognized, as are transient acute-phase reactions. Atrial fibrillation was first identified as a potential adverse event in a zoledronate trial, but subsequent trials and analyses failed to substantiate an association with bisphosphonates. Case reports have suggested a relationship between oral bisphosphonates and esophageal cancer, but this has not been demonstrated in epidemiologic studies. A possible association between bisphosphonate use and osteonecrosis of the jaw (ONJ) has also been suggested. However, the risk of ONJ in patients with osteoporosis appears to be very low, with no evidence from prospective RCTs of a causal association. There are reports of occasional occurrence of subtrochanteric or diaphyseal fractures in osteoporotic patients, but an association with bisphosphonate therapy is not substantiated by epidemiologic studies or prospective RCTs.
Text
tcrm-6-325.pdf
- Version of Record
More information
Published date: July 2010
Keywords:
bisphosphonates, osteoporosis, safety
Identifiers
Local EPrints ID: 162333
URI: http://eprints.soton.ac.uk/id/eprint/162333
ISSN: 1176-6336
PURE UUID: 15d67257-e7ad-4370-8b49-2db1c6e538f8
Catalogue record
Date deposited: 19 Aug 2010 07:49
Last modified: 18 Mar 2024 02:45
Export record
Altmetrics
Contributors
Author:
Michael Pazianas
Author:
F. Hal Ebetino
Author:
R. Graham G. Russell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics